Artiva Biotherapeutics, Inc. (ARTV)
3.30
+0.16
(+5.10%)
USD |
NASDAQ |
Dec 12, 16:00
3.29
-0.01
(-0.30%)
After-Hours: 20:00
Artiva Biotherapeutics Free Cash Flow: -78.90M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ovid Therapeutics, Inc. | -37.93M |
| Kezar Life Sciences, Inc. | -56.66M |
| Olema Pharmaceuticals, Inc. | -134.67M |
| Disc Medicine, Inc. | -166.03M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.20M |
| Cash from Investing (Quarterly) | 16.28M |
| Cash from Financing (Quarterly) | -0.037M |
| Free Cash Flow Per Share (Quarterly) | -0.8088 |
| Free Cash Flow to Equity (Quarterly) | -18.27M |
| Free Cash Flow to Firm (Quarterly) | -19.80M |
| Free Cash Flow Yield | -98.10% |